MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Sub-grouping of Parkinson’s disease based on thalamic subnuclei volume

S. Haji, W. Sako, H. Haginiwa, K. Kamagata, T. Hatano, N. Hattori (Bunkyo, Japan)

Meeting: 2025 International Congress

Keywords: Magnetic resonance imaging(MRI), Parkinson’s, Thalamus

Category: Parkinson's disease: Neuroimaging

Objective: We aimed to categorize Parkinson’s disease (PD) using k-means clustering based on thalamic subnuclei volumes measured by structural magnetic resonance imaging (sMRI).

Background: The thalamus, a relay nucleus in the input to the cerebral cortex, is divided into about 30 subnuclei according to the characteristics of the constituent neurons and input/output fibers. It is known that motor pathways, limbic pathways, and sensory pathways other than smell all pass through the thalamus and are also involved in the pathogenesis of PD. FreeSurfer (https://surfer.nmr.mgh.harvard.edu/) enabled us to calculate thalamic subnuclei volumes, based on which we may categorize patients with PD.

Method: We recruited 105 patients with sporadic PD (Male 56, median age 69.0, IQR 65.0-74.2) aged under 80 years and excluded patients with onset before 50 years old. All patients received 3T MRI. Cognition was assessed by Mini-Mental State Examination (MMSE), the Frontal Assessment Battery (FAB), and the Japanese version of the Montreal Cognitive Assessment (MoCA-J). Thalamic subnuclei volumes were calculated by FreeSurfer and the average of both side of thalamic subnuclei was used for analysis. After normalizing each thalamic subnuclei, k-means clustering was performed based on thalamic subnuclei volumes, and the optimal number of clusters was determined by Hubert index and elbow plot. Comparisons between clusters were conducted using the Kruskal-Wallis. Each thalamic subnuclei was further analyzed using multiple regression analysis (MRA), adjusting covariates including age and gender, to determine their association with cognitive function. Specific thalamic subnuclei including lateral dorsal nucleus (LD), lateral pulvinar nucleus (PuL), medial mediodorsal nucleus (MDm) were selected as covariates according to the previous reports.

Results: Significant differences between clusters were found for each cognitive scale (MMSE and MoCA-J, p < 0.01; FAB, p < 0.001). MRA showed that LD (p = 0.0003-0.045), PuL (p = 0.009-0.02), and age (p = 0.001-0.03) were significant factors in MMSE, MoCA-J, and FAB, while no significant association was found between MDm and those cognitive scales.

Conclusion: This study highlights that thalamic subnuclei may reflect cognitive function in PD. The identified thalamic subnuclei may serve as potential biomarkers for assessing cognitive variation in PD. Validation in external datasets is necessary to confirm these findings.

To cite this abstract in AMA style:

S. Haji, W. Sako, H. Haginiwa, K. Kamagata, T. Hatano, N. Hattori. Sub-grouping of Parkinson’s disease based on thalamic subnuclei volume [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/sub-grouping-of-parkinsons-disease-based-on-thalamic-subnuclei-volume/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/sub-grouping-of-parkinsons-disease-based-on-thalamic-subnuclei-volume/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley